ACADEMIC AND RESEARCH PEER-REVIEWED MEDICAL JOURNALISSN 1727-2378
Ru
En

Surgical Treatment of Graves’ Disease: a Consensus among Endocrinologists and Surgeons

DOI:10.31550/1727-2378-2019-159-4-46-48
Bibliography link: Petunina N.A., Trukhina L.V., Martirosyan N.S., Rogova M.O., Utsieva F.A., Ivanova G.N., Brevnona N.V. Surgical Treatment of Graves’ Disease: a Consensus among Endocrinologists and Surgeons. Doctor.Ru. 2019; 4(159): 46–48. DOI: 10.31550/1727-2378-2019-159-4-46-48
Surgical Treatment of Graves’ Disease: a Consensus among Endocrinologists and Surgeons
30 April 08:00

Objective of the Paper: To describe a clinical case of the manifestation and worsening of endocrine ophthalmopathy (EO) and pretibial myxedema after noncurative surgical treatment for Graves’ disease.

Key Points: Although near-total and total thyroidectomy are the generally accepted curative surgical treatment techniques for Graves’ disease, we still encounter outcomes of noncurative thyroidectomy and have to treat such patients. Postoperative recurrence of hyperthyroidism is especially undesirable, because repeat surgery is technically more challenging due to adhesions and is associated with increased risk of surgical complications.

This paper describes the clinical case of a patient with Graves’ disease who underwent a subtotal thyroidectomy. After surgery his EO worsened, posing a threat of loss of vision, and he developed pretibial myxedema. We believe that residual thyroid tissue supports an active autoimmune process in retrobulbar and pretibial tissue.

Conclusion: Near-total and total thyroidectomy should remain the techniques of choice for patients with Graves’ disease.

The authors declare that they do not have any conflict of interests.

N.A. Petunina — I.M. Sechenov First Moscow State Medical University (Sechenov University), Russian Ministry of Health; 2/44 Salam Adil St., Moscow, Russian Federation 123423. E-mail: napetunina@mail.ru

L.V. Trukhina — I.M. Sechenov First Moscow State Medical University (Sechenov University), Russian Ministry of Health; 2/44 Salam Adil St., Moscow, Russian Federation 123423. E-mail: lvtruhina@gmail.com

N.S. Martirosyan — I.M. Sechenov First Moscow State Medical University (Sechenov University), Russian Ministry of Health; 2/44 Salam Adil St., Moscow, Russian Federation 123423. E-mail: narinarine@list.ru

M.O. Rogova — I.M. Sechenov First Moscow State Medical University (Sechenov University), Russian Ministry of Health; 2/44 Salam Adil St., Moscow, Russian Federation 123423. E-mail: aniram12med@yandex.ru

F.A. Utsieva — I.M. Sechenov First Moscow State Medical University (Sechenov University), Russian Ministry of Health; 2/44 Salam Adil St., Moscow, Russian Federation 123423. E-mail: alima_ts@bk.ru

G.N. Ivanova — L.A. Vorokhobov City Clinical Hospital No. 67, Moscow City Department of Health; 2/44 Salam Adil St., Moscow, Russian Federation 123423. E-mail: endo2endo@yandex.ru

N.V. Brevnona — L.A. Vorokhobov City Clinical Hospital No. 67, Moscow City Department of Health; 2/44 Salam Adil St., Moscow, Russian Federation 123423. E-mail: endo2endo@yandex.ru

Surgical Treatment of Graves’ Disease: a Consensus among Endocrinologists and Surgeons
30 April 08:00
LITERATURE
  1. Braverman L.E., Utiger R.D. The thyroid: a fundamental and clinical text. 10th ed. Phylodelphia: Lippicott, Williams, Wilkins; 2012. 915 p.
  2. Laurberg P., Nygaard B., Andersen S., Carlé A., Karmisholt J., Krejbjerg A. et al. Association between TSH-receptor autoimmunity, hyperthyroidism, goitre, and orbitopathy in 208 patients included in the remission induction and sustenance in Graves’ disease study. J. Thyroid. Res. 2014; 2014: 165487. DOI: 10.1155/2014/165487
  3. Burch H.B., Burman K.D., Cooper D.S. A 2011 survey of clinical practice patterns in the management of Graves' disease. J. Clin. Endocrinol. Metab. 2012; 97(12): 4549–58. DOI: 10.1210/jc.2012-2802
  4. Li H.X., Xiang N., Hu W.K., Jiao X.L. Relation between therapy options for Graves' disease and the course of Graves' ophthalmopathy: a systematic review and meta-analysis. J. Endocrinol. Invest. 2016; 39(11): 1225–33. DOI: 10.1007/s40618-016-0484-y
  5. Tay W.L., Tong A.K.T., Hui K.Y.D., Tang Y.L.C., Chng C.L. Radioiodine associated de novo Graves' opthalmopathy in an Asian cohort. Hell J. Nucl. Med. 2017; 20(3): 227–31. DOI: 10.1967/s002449910606
  6. Ross D.S., Burch H.B., Cooper D.S., Greenlee M.C., Laurberg P., Maia A.L. et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016; 26(10): 1343–421. DOI: 10.1089/thy.2016.0229
  7. Lepner U., Seire I., Palmiste V., Kirsimägi U. Surgical treatment of Graves’ disease: subtotal thyroidectomy might still be the preferred option. Medicina. 2008; 44(1): 22–6.
  8. Трухина Л.В. Иммунологические, генетические и морфологические маркеры прогнозирования хирургического лечения диффузного токсического зоба: Автореф. дис. … канд. мед. наук. М.; 2005. 10 с. [Trukhina L.V. Immunologicheskie, geneticheskie i morfologicheskie markery prognozirovaniya khirurgicheskogo lecheniya diffuznogo toksicheskogo zoba: Avtoref. dis. … kand. med. nauk. M.; 2005. 10 s. (in Russian)]
  9. Lin Y.S., Lin J.D., Hsu C.C., Yu M.C. The long-term outcomes of thyroid function after subtotal thyroidectomy for Graves' hyperthyroidism. J. Surg. Res. 2017; 220: 112–18. DOI: 10.1016/j.jss.2017.06.091
  10. Meltzer C., Klau M., Gurushanthaiah D., Titan H., Meng D., Radler L. et al. Risk of complications after thyroidectomy and parathyroidectomy: a case series with planned chart review. Otolaryngol. Head Neck Surg. 2016; 155(3): 391–401. DOI: 10.1177/0194599816644727
  11. Sung T.Y., Lee Y.M., Yoon J.H., Chung K.W., Hong S.J. Long-term effect of surgery in Graves’ disease: 20 years experience in a single institution. Int. J. Endocrinol. 2015; 2015: 542641. DOI: 10.1155/2015/542641
  12. Liu Z.W., Masterson L., Fish B., Jani P., Chatterjee K. Thyroid surgery for Graves' disease and Graves' ophthalmopathy. Cochrane Database Syst. Rev. 2015; 11: CD010576. DOI: 10.1002/14651858.CD010576.pub2
  13. Sugino K., Nagahama M., Kitagawa W., Ohkuwa K., Uruno T., Matsuzu K. et al. Change of surgical strategy for Graves' disease from subtotal thyroidectomy to total thyroidectomy: a single institutional experience. Endocr. J. 2019; 66(2): 181–6. DOI: 10.1507/endocrj.EJ18-0324
Similar article
19 May 15:04, Allergology
V.M. Ganuzin, N.L. Chernaya, G.S. Maskova
Features of Specialised Medical Consultation of Adolescents with Bronchial Asthma: Clinical Observation
Doctor.Ru Pediatrics. Vol. 19, No. 3 (2020)
19 May 14:30, Allergology
S.E. Mitskevich, I.A. Fedorov, A.I. Chuprynina, O.G. Rybakova
Use of Omalizumab in Management of Severe Uncontrolled Bronchial Asthma in Children
Doctor.Ru Pediatrics. Vol. 19, No. 3 (2020)

Partners